Screener
Iovance Biotherapeutics, Inc. IOVA Net Income
Net Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Iovance Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Iovance Biotherapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 9:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091716
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Interest and other income, net | 3,217 | 4,104 | 4,550 | 7,324 |
| Net Loss before income taxes | $(48,688) | $(109,670) | $(128,398) | $(227,671) |
| Income tax benefit (expense) | 1,373 | (1,988) | 2,038 | (150) |
| Net Loss | $(47,315) | $(111,658) | $(126,360) | $(227,821) |
| Net Loss Per Share of Common Stock, Basic and Diluted | $(0.11) | $(0.33) | $(0.29) | $(0.69) |
| Weighted Average Shares of Common Stock Outstanding, Basic and Diluted | 450,189 | 334,511 | 434,437 | 328,721 |
| * Non-cash stock-based compensation included in cost of sales and operating expenses | ||||
| Cost of sales | $1,536 | $2,149 | $2,555 | $4,569 |
Item 1.Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Iovance Biotherapeutics, Inc.'s net income?
- Iovance Biotherapeutics, Inc. (IOVA) reported net income of -$47.32M in Q2 2026.
- How has Iovance Biotherapeutics, Inc.'s net income changed year-over-year?
- Iovance Biotherapeutics, Inc.'s net income increased by 57.6% year-over-year, from -$111.66M to -$47.32M.
- What is the long-term trend for Iovance Biotherapeutics, Inc.'s net income?
- Over 4 years (2021 to 2025), Iovance Biotherapeutics, Inc.'s net income has grown at a 3.4% compound annual growth rate (CAGR), from -$342.25M to -$390.98M.
- What does net income mean?
- Net income as the starting point for the indirect method operating cash flow reconciliation.
Ask your AI about Iovance Biotherapeutics, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude